Pharmaceutical

Abortion funds run short of money as demand soars and d...

Some abortion funds went from supporting 100 abortions a month to 100 a week. Wi...

Bayer in artificial intelligence: theme innovation stra...

How many patents did Bayer submit related to artificial intelligence last quarte...

Genentech signs nanoparticle deal worth up to $644m wit...

Genentech will utilise GenEdit’s non-viral polymer nanoparticles for gene therap...

Sanofi signs agreement to acquire Inhibrx for $1.7bn

Sanofi has signed a definitive agreement for the acquisition of all outstanding ...

Inhalation Sciences and Actarmo enter respiratory drugs...

Inhalation Sciences has entered into a collaboration with Germany-based Actarmo ...

UK MHRA strengthens regulations on fluoroquinolone anti...

The UK MHRA has introduced further restrictions on the usage of fluoroquinolone ...

NS Pharma gains EC orphan drug designation to treat EGPA

NS Pharma has received orphan drug designation from the European Commission for ...

A ‘sense of urgency’ swirls in the UK pharma regulatory...

The UK government adopted a series of updates to pharmaceutical laws, governing ...

F. Hoffmann-La Roche in cybersecurity: theme innovation...

How many patents did F. Hoffmann-La Roche submit related to cybersecurity last q...

Cara Therapeutics cuts 50% of staff and drops kidney di...

The company ceased activity for its CKD program to sharpen its clinical focus in...

Newly launched Calluna raises $81m to advance monoclona...

Calluna has four monoclonal antibody candidates in the pipeline under developmen...

Investigators fault Lilly plant for manufacturing issues

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Gilead’s Trodelvy fails in lung cancer and raise...

Gilead said Trodelvy, its medicine that combines an antibody with chemotherapy, ...

Opinion: STAT+: Some countries are moving to digital pr...

Some countries are moving to digital prescription drug information for patients....

Opinion: The FDA and FTC need to crack down on TikTok a...

The FDA and FTC need to crack down on influencers advertising prescription drugs.

STAT+: A Harvard course seeks to put food on the table ...

As movements promoting food as medicine gain traction, many medical students wan...